Company / Current Liabilities per Share
Mirum Pharmaceuticals, Inc. Current Liabilities per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$4.26
FY2025
5-year range
$1.43 / $4.26
FY2021-FY2025
Trend
+57.2%
vs FY2024
Sector context
#44 of 210
Health Care
What the data says
Mirum Pharmaceuticals, Inc.'s current liabilities per share of $4.26 is higher than 79% of companies in the Health Care sector (FY2025). Current Liabilities per Share has increased for 5 consecutive years, from $0.73 in FY2020 to $4.26 in FY2025.
Based on SEC 10-K filings.
4.26 in FY2025 with a 5-year CAGR of +42.2%. Top quartile in the Health Care sector.
Increased from $2.36 to $4.26 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +26.2%
- 5-Year CAGR
- +42.2%
- 10-Year CAGR
- -
Sector benchmark
-73.0% below sector average
Key checks
Key Insights
- Mirum Pharmaceuticals, Inc.'s current liabilities per share has grown for 5 consecutive years.
- In FY2025, current liabilities per share increased 57.2% year-over-year.
- Ranks #44 out of 210 companies in the Health Care sector.
- Lowest current liabilities per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -26.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.26 | +57.2% |
| FY2024 | $2.71 | +15.0% |
| FY2023 | $2.36 | +11.3% |
| FY2022 | $2.12 | +48.0% |
| FY2021 | $1.43 | +95.7% |
| FY2020 | $0.73 | -35.8% |
| FY2019 | $1.14 | -58.2% |
| FY2018 | $2.72 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026